CPVI Alone Versus. CPVI Plus Electrophysiological Substrate Ablation in the LA During SR for the Treatment of Non-PAF (STABLE-SR_II)
Circumferential Pulmonary Vein Isolation Alone Versus. Circumferential Pulmonary Vein Isolation Plus Electrophysiological Substrate Ablation in the Left Atrium During Sinus Rhythm for the Treatment of Non-paroxysmal Atrial Fibrillation
Sponsor: Asklepios Kliniken Hamburg GmbH
Listed as NCT03448562, this NA trial focuses on Atrial Fibrillation and remains ongoing. Sponsored by Asklepios Kliniken Hamburg GmbH, it has been updated 8 times since 2018, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Mar 2022 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Mar 2022 [monthly]
Recruiting NA
-
Mar 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 3 earlier versions
-
Dec 2019 — Mar 2020 [monthly]
Not Yet Recruiting NA
-
Jun 2018 — Dec 2019 [monthly]
Not Yet Recruiting NA
-
Mar 2018 — Jun 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Asklepios Kliniken Hamburg GmbH
- First Affiliated Hospital of Wannan Medical College
- First Affiliated Hospital of Zhejiang University
- First Affiliated Hospital, Sun Yat-Sen University
- Fudan University
- General Hospital of Shenyang Military Region
- German Heart Institute
- Guangdong Provincial People's Hospital
- National Heart Centre Singapore
- National University Hospital, Singapore
- Royal Brompton & Harefield NHS Foundation Trust
- Semmelweis University Heart and Vascular Center
- Southlake Regional Health Centre
- The First Affiliated Hospital with Nanjing Medical University
- The Second Hospital of Hebei Medical University
- University of Minnesota
- University of Pennsylvania
- Zhongda Hospital
For direct contact, visit the study record on ClinicalTrials.gov .